Scholarly article on topic 'Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)'

Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD) Academic research paper on "Clinical medicine"

0
0
Share paper
Academic journal
Biogerontology
OECD Field of science
Keywords
{""}

Academic research paper on topic "Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)"

Biogerontology (2013) 14:461-482 DOI 10.1007/s10522-013-9463-2

REVIEW ARTICLE

Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)

Paulina Tokarz • Kai Kaarniranta • Janusz Blasiak

Received: 14 March 2013/Accepted: 3 September 2013/Published online: 22 September 2013 © The Author(s) 2013. This article is published with open access at Springerlink.com

Abstract Cells in aerobic condition are constantly exposed to reactive oxygen species (ROS), which may induce damage to biomolecules, including proteins, nucleic acids and lipids. In normal circumstances, the amount of ROS is counterbalanced by cellular antioxidant defence, with its main components— antioxidant enzymes, DNA repair and small molecular weight antioxidants. An imbalance between the production and neutralization of ROS by antioxidant defence is associated with oxidative stress, which plays an important role in the pathogenesis of many age-related and degenerative diseases, including age-related macular degeneration (AMD), affecting the macula—the central part of the retina. The retina is especially prone to oxidative stress due to high oxygen pressure and exposure to UV and blue light promoting ROS generation. Because oxidative stress has an established role in AMD pathogenesis, proper functioning of antioxidant defence may be crucial for the

P. Tokarz (&) • J. Blasiak

Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland e-mail: ptokarz@biol.uni.lodz.pl

K. Kaarniranta

Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

K. Kaarniranta

Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland

occurrence and progression of this disease. Antioxi-dant enzymes play a major role in ROS scavenging and changes of their expression or/and activity are reported to be associated with AMD. Therefore, the enzymes in the retina along with their genes may constitute a perspective target in AMD prevention and therapy.

Keywords AMD • Oxidative stress • Antioxidant enzymes • Small molecular weight antioxidants • ROS • Retinal pigment epithelium

Introduction

Age-related macular degeneration (AMD) is a progressive disease of the central part of the retina, which may lead to a partial or complete vision loss in one or both eyes among people aged 55 years and older in developed countries. The disease may be accompanied by the reduction of the visual acuity, however, the absence of visual impairment does not exclude AMD (Bird et al. 1995). The major pathological changes associated with AMD are observed in the functionally and anatomically related tissues, including photoreceptors, retinal pigment epithelium (RPE), Bruch's membrane and cho-riocapillaries (Bhutto and Lutty 2012). Classically, two subgroups of AMD are distinguished, atrophic (dry, non-exudative) AMD, characterized by the degradation of RPE and secondary photoreceptors in the macular area and as a consequence the accumulation

of extracellular deposits denoted drusen between the RPE and Bruch's membrane; and exudative (wet, neovascular) AMD associated with choroidal neovascularization (CNV), which may cause the detachment of RPE or retina, exudation, haemorrhages, inflammation and scar tissue formation in the retina (Bird et al. 1995). The most common form of advanced AMD is the dry one, but it may progress to the wet form, which contributes to rapid loss of vision (Fine et al. 2000). The wet form of AMD occurs less frequently (15 %) than the dry one (85 %), but it accounts for two-third of individuals who have significant visual loss, according to macular degeneration association estimates (MDA 2013). AMD is the third cause of blindness globally and the primary cause (approximately 50 % of legal blindness incidence) in industrialized countries as reported by World Health Organization (WHO) (2013). According to the National Eye Institute (NEI) calculations, there is a higher prevalence of AMD in white people than in other races, and that this disease is more common in women (65 vs. 35 % in men in US in 2010) (NEI 2013). In addition, the number of AMD incidence has increased by 18 % since 2000 till 2010 and is expected to double by the year 2020. Since AMD is uncommon among people under the age of 50, the increase in the absolute number of affected people globally may be a consequence of population aging. Initiation and progression of AMD may be induced by genetic, epigenetic and environmental risk factors. Apart from positive correlation of the disease with age, other risk factors are prevalent, the most important being cigarette smoking, white race, female sex, blue iris colour, obesity, nutritional factors and insufficient antioxidants in the diet (Kaarniranta et al. 2011). However, the pathogen-esis of AMD is still elusive, likely due to its multifac-torial etiology. It is believed that the senescence of RPE cells and Bruch's membrane, the impaired blood flow in the vascular membrane of eye, the retina exposure to UV and blue light and the genetic predisposition play a significant role in the development of AMD (Majji et al. 2000; Tanito et al. 2007). Also, oxidative stress is believed to contribute to the pathogenesis of AMD and its role in generating cellular damage in RPE cells and choriocapillaris is well documented (Lu et al. 2006). It is presumed that the loss of RPE cells is an early event in AMD (Dorey et al. 1989). The RPE cells degradation is mainly attributed to oxidative stress, which may be a consequence of attenuated antioxidant cell defense systems or augmented level of ROS (Justilien et al.

2007). Oxidative stress, generated by the oxygen-rich environment and the exposure to light in the eye, modifies the compounds in the photoreceptors, which are then shed in the form of photoreceptor outer segments (POS) and phagocyted by RPE cells (Beatty et al. 2000). RPE consists of postmitotic cells, which are thus deprived of the ability to propagate (Klein et al. 1990). Due to this, RPE cells accumulate damage during the life-span and the extent of such changes increases with age (Cai et al. 2000). These changes include the dysfunction of RPE cells metabolism and insufficiency in their phagocytic function (Chen et al. 2009a). The depletion of these protective mechanisms in RPE cells may lead to the accumulation of toxic photoproducts and further generation of ROS. The increasing concentration of ROS may lead to damage to organelles, including mitochondria and lysosomes (Chen et al. 2009a; Blasiak et al. 2013). The process of ROS formation at the mitochondria is known as the vicious cycle, in which one process stimulates the other (Blasiak et al. 2013). Besides lysosomal degradation, other cell clearance systems, including autophagy, may be altered in AMD (Kaarniranta et al. 2013). The resulting decrease in cellular components degradation propels lipofuscinogenesis (Krohne et al. 2010). Elevated level of undigested or insoluble material in the form of lipofuscin may induce apoptosis (Sparrow et al. 2000). Since RPE cells are postmitotic, their death results in the reduction of RPE cell density in the RPE layer (Del Priore et al. 2002). Thus the remaining RPE cells face a higher number of ROS. This increases oxidative stress in RPE cells promoting pathogenic processes (Strauss 2005). All these processes are enhanced by the age-dependent decline in the level of antioxidants, the most significant being a-tocopherol (Friedrichson et al. 1995). Also hypopigmentation—a noticeable sign of melanosomes photobleaching—augments in the age-dependent manner (Feeney-Burns et al. 1984). The reduction in the number of melanosomes combined with the attenuation of their photo-protective function may propel the progression of AMD (Zadlo et al. 2007). When RPE cells become insufficient to store shed POS or when RPE cells are degraded, POS may be stored between Bruch's membrane and RPE layer as drusen (Strauss 2005). The negative effect of drusogenesis is twofold. First, drusen stimulate inflammation. The analysis of drusen revealed the presence of various proteins, including major histocompatibility complex (MHC) class II antigens (Johnson et al. 2000), proteins

associated with the activation of the immune system, including p-amyloid, C-reactive protein (CRP) or membrane attack complex—MAC (Anderson et al. 2002, 2004; Mullins et al. 2000). Drusen activated macrophages to clear some of drusen components and to express scavenger receptors (Kamei et al. 2007; Luh-mann et al. 2009). The impairment of macrophage-mediated clearance system may result in the overwhelming amount of pro-inflammatory deposits leading to the recruitment of tissue-destructive macrophages and the activation of the complement system. Second, the presence of drusen between two functionally and structurally interacting tissues may hinder the process of oxygen and nutrients delivery to RPE cells by Bruch's membrane (Strauss 2005). The depletion of these compounds may be an onset ultimately leading to imbalance between pro-angiogenic and anti-angiogenic factors resulting in the neovascularization and progressing from dry to wet AMD (Frank 1997). It is suggested that the excess of pro-angiogenic compounds such as FGF, TNF-a and matrix metalloproteinases (MMPs) is released by neutrophils, mast cells and macrophages at the site of pro-inflammatory drusen deposites (Kijlstra et al. 2005).

Oxidative stress in the retina

The generation and neutralization of radicals, molecules with unpaired electron(s) is a physiological process. Provided that radicals are effectively scavenged by the cellular antioxidant defence systems, their presence is not detrimental. The imbalance between oxidants and antioxidants in favour of the oxidants, results in oxidative stress. This is a pathogenic condition leading to damage of numerous cellular components including lipids, proteins and nucleic acids. A concept formulated by Denhama Harman states that aging is a result of ROS-induced damage accumulation (Harman 1956). Experimental data support this thesis as oxidative stress may accelerate the process of aging and may play a role in the pathogenesis of many aging-related diseases including AMD (Chiba et al. 2009).

The retina is a tissue abundant in ROS (Fig. 1). First, the oxygen consumption in the retina is the highest among all human tissues (Yu and Cringle 2001). Second, RPE and photoreceptors are exposed to high-energy light, which is focused in the macula

(Youssef et al. 2011). Third, the cell membrane of photoreceptors is rich in polyunsaturated fatty acids (PUFA), which are readily oxidized (Anderson et al. 1974). Fourth, there are many photosensitizers in RPE and photoreceptors (Hunter et al. 2012). Finally, the phagocytosis of POS conducted by RPE cells may be accompanied by a respiratory burst—a rapid eruption of ROS (Miceli et al. 1994). POS which are wearing out contain lipids, proteins and others oxidized particles, the driving force of a respiratory burst, born as a result of exposure to light and oxygen-rich environment in the photoreceptors (Tate et al. 1995).

Oxygen consumption

Photoreceptors, cells of high metabolic activity, are in a high demand for oxygen and nutrients, which are delivered through blood vessels. Due to the high consumption of oxygen, its supply in the retina is higher than in other tissues (Yu and Cringle 2001). The high partial pressure of oxygen promotes generation of ROS in the retina (Fig. 1). Mitochondria are a major source of ROS and thus they are perturbed by oxidative stress (Cui et al. 2012). This is of a special importance in the context of mitochondrial DNA (mtDNA), which may be more susceptible to oxidative damage than nuclear DNA (Ballinger et al. 1999; Jin et al. 2001). This fact is mainly attributed to the mtDNA proximity to the source of ROS production, the lack of mtDNA protection by histones and other DNA-associated proteins, the lack of introns in mtDNA and the less effective mtDNA repair systems in comparison to nuclear DNA (Desler et al. 2011). That is why mtDNA rapidly accumulates mutations, which further can cause disorder of the respiratory chain function leading to generation of ROS (Cui et al. 2012). Non-dividing cells, including RPE cells, are particularly prone to accumulate mtDNA damage due to their inability to reduce defective mitochondria during mitosis. Changes in mitochondrial number, size, shape, matrix density, cristae architecture and membrane integrity were distinct in RPE cells obtained from donors aged 60 and more when compared to those obtained from younger individuals (<60 years) (He et al. 2010). These mitochondria dysfunctions were associated with low ATP level, attenuated mitochondrial membrane potential, reduced cytoplasmic Ca2+ and augmented mitochondrial Ca2+ sequestration. Knockdown of MnSOD

Fig. 1 Schematic presentation of ROS involvement in AMD pathology

(superoxide dismutase, which binds manganese), an antioxidant mitochondrial enzyme, stimulated a long-term mitochondrial oxidative stress, which evoked the increase in superoxide anion, apoptotic cell death, degeneration of RPE cells, thickening of Bruch's membrane, shortening and disorganisation of the photoreceptor outer and inner segments (Justilien et al. 2007).

Irradiation

Radiation reaching the eye is partly absorbed by the cornea and lens, whereas the rest of it (400-760 nm) penetrates the eye reaching the retina, where it may induce damage to retinal cells (Chalam et al. 2011; Fig. 1). It was demonstrated that the exposure of the retina to blue light (441 nm) in vivo resulted in the damage to POS, the cellular proliferation, the mitotic alterations in the RPE and choroidal cells and the RPE pigment mottling—signs resembling atrophic changes in AMD (Ham et al. 1978). Other study also showed that constant illumination of the retina led to the

damage of photoreceptors in vivo (Wiegand et al. 1983). The link between irradiation and oxidative stress was observed when light-induced retinal damage stimulated the expression of oxidative stress-inducible heme oxygenase-1 (HO-1) (Organisciak et al. 1998). The administration of antioxidants before radiation exposure protected the retina from the damage (Organisciak et al. 1998; Ranchon et al. 1999; Lam et al. 1990). Blue light seems to be the most dangerous to RPE, not only because it is the most energetic radiation reaching the monolayer of RPE cells, but also because it promoted photooxidation of lipofuscin generating the reactive photoproducts including-N-retinylidene-N-retinylethanolamine (A2E), cell apoptosis and DNA oxidation (Sparrow et al. 2000, 2002, 2003; Sparrow and Cai 2001).

Polyunsaturated fatty acids

Photoreceptor's membrane is characterised by a unique composition of lipids, predominantly containing PUFAs, with the most abundant representative

being docosahexanoic acid (DHA) (22:6 ra3), exclusively of dietary origin. Since the susceptibility of unsaturated fatty acids to oxidation increases with the number of double bonds, the photoreceptors are particularly vulnerable to lipid peroxidation (Witting 1965). This process may produce peroxides and organic radicals, which may cause functional and structural damage to cell membrane resulting in the degeneration of photoreceptors (Anderson and Krin-sky 1973; Arstila et al. 1972). Retinal damage was significantly reduced in rats fed a diet deficient in DHA or linoleic acid, a DHA precursor (Bush et al. 1991; Organisciak et al. 1996). The age-dependent susceptibility of the posterior pole retina to lipid peroxidation was observed suggesting the attenuation of antioxidant defence systems with aging (De La Paz and Anderson 1992).

Photosensitizes

Photosensitizes are chemical compounds that absorb light and subsequently emit radiation, which may induce chemical reactions contributing to cell photochemical damage (Fig. 1). There are a few photosensitizes, including rhodopsin, lipofuscin, melanin and the mitochondrial respiratory enzymes, e.g. cyto-chrome c oxidase, which were demonstrated to be essential factors for photodamage generation in the retina (Hunter et al. 2012).

The degree of retinal degeneration positively correlated with the rhodopsin content in the retina before light exposure (Rapp and Williams 1979, 1980; Organisciak and Winkler 1994; Organisciak et al. 1991). The susceptibility to light-induced damage ameliorated with age as assessed by the level of recovered rhodopsin after light exposure (Organisciak et al. 1998). Administration of antioxidants, including ascorbate, ascorbic acid and dimethylthiourea (DMTU) led to an inhibition of rhodopsin loss in the retina suggesting oxidative nature of rhodopsin-mediated photodamage (Organisciak et al. 1985, 1990, 1992, 1998). In support of this statement, the DMTU treatment of the light-exposed rats suppressed the induction of HO-1 mRNA encoding oxida-tive stress-induced enzyme (Organisciak et al. 1998).

Lipofuscin, an aggregate primarily consisting of lipids, proteins and pigment derivatives such as A2E, is progressively accumulated in dysfunctional RPE cells (Delori et al. 2001). It was shown that the illumination of RPE cells with blue light induced the oxygen uptake

in an age-dependent manner (Rozanowska et al. 1995). The observed photoreactivity of RPE cells was mainly attributed to lipofuscin, which generated ROS including singlet oxygen, superoxide anion and hydrogen peroxide (H2O2) under aerobic conditions. This photoinduc-ible generation of radicals was shown to result in lipid peroxidation, partial or complete inactivation of anti-oxidant enzymes, including SOD and catalase, in RPE cells and RPE cellular dysfunction (Wassell et al. 1999; Shamsi and Boulton 2001). Also, the exposure of A2E to blue-light initiated the production of ROS and induced apoptosis in ARPE-19 cells (Sparrow et al. 2000). However, the illumination of ARPE-19 cells with blue light in the absence of A2E, did not promote cell death. The accumulation of A2E led to the dysfunction of lysosomes in a dose-dependent manner, which is a prerequisite for the pathogenesis of diseases associated with excessive lipofuscin accumulation, including AMD (Holz et al. 1999). The illumination of cells inhibited the cytochrome oxidase activity in the light-intensity-dependent manner in the presence of AE2 in the cells inducing impaired electron flow in the respiratory chain (Shaban et al. 2001).

Inflammation

Although AMD is not considered a typical inflammatory disease, the pathogenic role of immunologic processes in the occurrence and progression of AMD is well documented. The correlation between immuno-logical/inflammatory gene polymorphisms and AMD indicates the involvement ofinflammation and immunemediated processes—complement activation, in the pathogenesis of this disease (Bergeron-Sawitzke et al. 2009; Ryu et al. 2010). Furthermore, immunocompetent cells, such as macrophages and lymphocytes, were present in the chorioretinal tissues affected by AMD (Penfold et al. 1985; Lopez et al. 1991). Also, the complement pathway was deregulated in eyes from AMD patients. It was demonstrated that oxidative damage induced inflammation and initiated formation of AMD-like lesions, including drusen accumulation next to the RPE layer upon aging, development of lesions mimicking geographic atrophy (GA) in RPE and the blindness in mice, indicating a direct link between oxidative damage and inflammatory response in AMD (Hollyfield et al. 2008). Thus, it may be expected that modulation of the level of oxidative damage may

influence the inflammatory response. Also, the relationship showing the stimulation of antioxidant enzyme activity upon administration of acute inflammatory response inductor, endotoxin, in the rabbit eye was manifested (Recasens and Green 1992). Endotoxin administration was associated with a significant SOD induction in choroids and retinas of adult animals, but not of aged animals. This effect may be indicative of the vulnerability of ocular tissues from aged animals to inflammation-related oxidative stress due to their inability to induce SOD in response to an inflammatory stimulus.

Antioxidant defence

Because of many studies demonstrating a causative role of oxidative stress in the etiopathogenesis of AMD, the antioxidant status in individuals with and without this disease was extensively investigated. Although the majority of studies conducted in vitro and in vivo indicate a protective role of antioxidants, the population-based studies on dietary antioxidant intake lack consistency and reliability. The confounding data are derived from multiple interactions between compounds taken with food. Data collected by the National Health and Nutrition Examination Survey (NHANES) showed that the consumption of fruit and vegetables, being a source of antioxidants, negatively correlated with the occurrence of AMD (Goldberg et al. 1988). However, other factors, including increased concern in healthy lifestyle of vegetarians, were not taken into account in this study.

Pigments

To protect the eye from the high energy radiation the RPE cells are equipped with the specialised set of various pigments which absorb part of light and thus constitute a radiation filter for cells (Beatty et al. 1999, 2000, 2001). The majority of light is absorbed via melanin present in melanosomes (Boulton 1998). The remaining part of the light spectra is absorbed by photoreceptors and their pigments—carotenoids, lutein and zeaxanthin, which are selectively accumulated in the retina (Bone et al. 1985). These carote-noids are referred to as macular pigment, which is thought to shield photoreceptors from blue light since it reduces the amount of light, which reaches

photoreceptors by approximately 40 % (Bone et al. 1997; Snodderly et al. 1984; Fig. 1). The maximum absorption wavelength for A2E is near 450 nm (blue light). High absorption of this range of wavelength (absorbance spectrum peaks at 460 nm) by macular pigment prevents A2E oxidation and subsequent generation of ROS (Haegerstrom-Portnoy 1988; Junghans et al. 2001; Landrum and Bone 2001; Pease et al. 1987). Apart from being a blue light filter, carotenoids manifest their antioxidant properties through quenching reactive oxygen intermediates (Foote and Denny 1968; Krinsky and Deneke 1982). The distribution of these carotenoids was unequal in the retina. Zeaxanthin is abundant in the macula and lutein in the peripheral retina, which suggests different functions of these pigments (Bone et al. 1988, 1997). Carotenoids ability to scavenge free radicals was increased with decreasing oxygen partial pressure as assessed through the measurement of lipid peroxida-tion in a chemical model, indicating that the efficiency of these ROS scavengers may be modulated by oxygen concentration (Jorgensen and Skibsted 1993). Although it was not demonstrated, it may be supposed that the antioxidant activity of carotenoids may be reduced under oxidative stress. Carotenoids may interact with other antioxidants complementing their function, such as the a-tocopherol regeneration or the enhancement of antioxidant action of vitamin C (Edge et al. 1997; Packer 1993). The majority of studies including population-based case-control and cohort studies indicated a protective effect of lutein and zeaxantine (assessed by plasma or serum level measurements or interview-based intake estimations) in relation to AMD, especially its wet form (Eye Disease Case-Control Study Group 1993; Snellen et al. 2002; Delcourt et al. 2006). However, oppose effects in serum have also been demonstrated (Mares-Perlman et al. 1995). Recent study conducted within the age-related eye disease study 2 (AREDS2) project manifested a high macular pigment optical density (MPOD), indicator of macula health, in individuals supplemented with 10 mg of lutein and 2 mg of zeaxanthin per day, when compared with control group not receiving this supplementation (Bernstein et al. 2012). Concordant results were obtained from the mouse model, DKO mice, which develop focal retinal lesions that had clinical, biochemical, and pathological features of AMD, including the degeneration and atrophy of focal photoreceptors and RPE (lipofuscin

accumulation, hypertrophy, and hypotrophy) as well as the presence of some drusenoid deposits (Ramkumar et al. 2010, 2013; Tuo et al. 2007; Zhang et al. 2013). Although this model lacks a macula (like all nonprimate models), it adopts the accumulation of A2E and the degeneration of focal photoreceptor and RPE, which are found in AMD. The supplementation of mice with lutein, zeaxanthin, and long-chain n3 PUFAs: docosahexaenoic acid (DHA) and eicosapentaenoic-acid (EPA) demonstrated a benefit of the AREDS2 diet on retinal AMD-like lesions on the clinical and histopathological level including the accumulation of RPE lipofuscin and A2E, the pathologic gene expression as well as the preservation of photoreceptors in comparison to DKO and wild-type mice fed with either normal or with isocaloric diet. The AREDS2 studies conducted on the 1,608 participants showed no reduction in progression to advanced AMD in patients supplemented with lutein and zeaxanthin or DHA and EPA or 4 these compounds in comparison to individuals receiving placebo. It is worth noting that although there is a large body of evidence in favour of the role of lutein in the retina functioning, its participation in the development of AMD remains a matter of debate. The new light was recently shed on the influence of lutein on the inflammation. Data collected from epidemio-logical studies revealed an inverse dependency between lutein concentration in serum and circulating inflammation markers, such as intercellular adhesion molecule 1 (ICAM-1) and CRP (van Herpen-Broek-mans et al. 2004; Seddon et al. 2006). Other study, in which CRP level was also compared, did not confirm this finding (Kritchevsky et al. 2000). This may be attributed to the fact that only healthy individuals, who might have had too low initial level of inflammatory biomarkers, were taken into the examination (Kijlstra et al. 2012). In vivo experiments, conducted on laser-stimulated mouse model of CNV, revealed that the administration of lutein before exposure to laser resulted in the decreased volume of CNV, the inhibited infiltration of macrophages into the CNV area of the retina and the down-regulated expression of pro-inflammatory proteins, including CCL2 (monocyte chemotactic protein-1), vascular endothelial growth factor (VEGF) and ICAM-1 as compared to controls (Izumi-Nagai et al. 2007). Pre-treatment with lutein inhibited the inflammation and therefore the activation of NF-kB, which is one of the factors causing the development of CNV. Moreover, the experiments

in vitro demonstrated that lutein exposure blocked TNF alpha- or lipopolysaccharide-induced expression of NF-kB in ARPE-19 cells and macrophages, respectively (Izumi-Nagai et al. 2007; Kim et al. 2008). Thus recent literature indicates three functions of lutein in the retina: a blue light filter, a ROS scavenger and a blocker of inflammatory response.

Vitamins

Vitamins C and E play an important role as antiox-idants in the prevention of AMD. Vitamin C acts as a ROS scavenger and reconstitutes vitamin E, which is anchored in the cell membrane and prevents lipid peroxidation (Beatty et al. 2000; Sies et al. 1992; Fig. 1). The studies on animals showed that the pre-exposure supplementation with vitamin C reduced the rod cell loss and preserved DHA in outer segment of these cells (Organisciak et al. 1985). The deficiency of vitamin E led to the retina degradation, the augmented lipofuscinogenesis in RPE, the decrease in the PUFA level in rod outer segments and RPE as well as the augmented sensitivity of the retina to photo-oxidative damage (Hayes 1978; Farnsworth et al. 1979; Beatty et al. 2000). However, the population-based studies are incoherent in results on the protective action of vitamin C or vitamin E. The supplementation of vitamin C at 500 mg each day or of vitamin E at 400 IU the alternate days (doses applied in the AREDS formulation) had no effect on the incidence of the diagnosis of AMD in 14 236 men aged >50 after 8 years of treatment (Christen et al. 2012). This lack of association between vitamin C or vitamin E intake and AMD may be attributed to a weak protective effect of dietary vitamins, which may be below the detection limit or the period of high dose intake of vitamins was too short. Recent report demonstrated that the oral preparation containing lutein, zeaxanthin, vitamin C, vitamin E, copper, and zinc led to the functional and morphologic benefits in patients with early AMD (Beatty et al. 2013). Since an individual diet includes a battery of distinct antioxidants, the assessment of the selected compound is a difficult task. Although it seems that the individual components of the AR-EDS formulation may evoke a weak protective effect, their combination may be strong enough to provide beneficial effect to the treatment/prophylaxis of AMD.

Minerals

Minerals may function as regulators of antioxidant enzymes, thus their deficiency may negatively affect the cellular antioxidant defence system (Fig. 1). The alterations in the level of elements in aqueous humor of patients with dry AMD confirmed that the disturbance in mineral homeostasis is associated with AMD (Junemann et al. 2013). AMD patients had significantly elevated concentration ofzinc, cadmium, cobalt and iron. On the other hand, the concentration of copper was diminished in patients with AMD. However, no significant difference was observed for manganese and selenium. Zinc regulates the activity of CuZnSOD and catalase, induces the expression of metallothionein—a cystein-rich protein that provides protection from oxidative stress and interacts with retinol dehydrogenase, which participates in the restoration of retinol in the visual cycle (Tate et al. 1997; Sato and Bremner 1993). The level of zinc was reduced in RPE, choroid complex and neural retina of patients with AMD when compared to control (Erie et al. 2009). The accumulation of lipofuscin was observed in the RPE of rats on a zinc scarce diet (Julien et al. 2011). This was accompanied by the appearance of macrophages in the choroids as well as at Bruch's membrane, indicating that zinc may participate in the inflammatory response in the retina. The zinc supplementation at 80 mg/day for 2 years protected AMD patients from loss of visual acuity (Newsome et al. 1988). Among zinc-supplemented individuals loss of visual acuity occurred in 3.8 % patients, whereas in patients taking placebo it was 10 %. Zinc is also included in the ARDES formulation—the antioxidant cocktail utilized for AMD treatment. Beside zinc in the cocktail formulation, there is copper, which is included in order to prevent copper deficiency anemia, a condition associated with high level of zinc intake. Similarly as zinc, manganese is a cofactor of antioxidant enzyme, MnSOD. Cadmium, rated as the 8th most toxic substance by the agency for toxicity and disease registry priority list of hazardous substances, accumulates in aging human retinal tissues and its level is doubled in the neural retina and RPE from AMD-affected eyes when compared with controls (Wills et al. 2009; ATSDR 2005). Interestingly, cadmium content was higher in females than males for both control and AMD-affected eyes reflecting the gender differences in the

AMD prevalence. It was demonstrated that cadmium might interfere with the metabolism of zinc by binding to the zinc transport proteins (Girijashanker et al. 2008). Since these proteins have high affinity for cadmium thus cadmium may deplete zinc level in the retina through cadmium competition with zinc for these transporters. Pre-treatment of ARPE-19 cells with either manganese or zinc prevented cadmium accumulation in these cells (Satarug et al. 2008). Manganese demonstrated a stronger effect in blocking cadmium uptake than zinc and it induced the expression of HO-1 on mRNA and protein levels suggesting that manganese may enhance resistance to oxidative stress in RPE cells. Apart from zinc, cadmium competes with other metals, including manganese, calcium and iron for metal transporter protein(s) in order to enter the cells (Bannon et al. 2003; Martin et al. 2006; He et al. 2006). We have demonstrated the association between polymorphism in genes encoding enzymes regulating iron homeostasis including trans-ferrin gene and the iron-regulatory protein-1 and -2 genes as well as in the generation and removal of iron-mediated oxidation: NQO1, NOS3 and NFE2L2 and the occurrence of AMD (Wysokinski et al. 2013; Synowiec et al. 2012, 2013).We have also found that the serum level of transferrin was higher in AMD patients when compared with those without AMD (Wysokinski et al. 2013). In support of this observation, the level of transferring was increasing during the course of rapidly progressing retinal degeneration in rd10 mice when compared with controls at the same age (Deleon et al. 2009). Furthermore, age-related iron accumulation impaired the phagocytosis and lyso-somal functions of RPE cells in the aged rodents— dysfunctions associated with AMD (Chen et al. 2009a). Recent findings showed that iron chelator was protective against the light-induced retinal degeneration and reduced oxidative stress in mouse retina indicating a crucial participation of iron in the generation of oxidative stress in the retina (Song et al. 2012). Selenium is an activator of glutathione peroxidase (Gpx) (Singh et al. 1984). Currently undergoing clinical trial SELECT examining the protective effect of selenium in AMD in men should clarify whether this element plays a role in the pathogenesis of AMD. Regardless of this trial, selenium inhibited VEGF production in the epithelial cancer cells in vitro (Jiang et al. 2000). Thus it is possible that selenium could also participate in the

regulation of angiogenesis in the eye impeding the development of wet AMD.

Enzymatic antioxidants

Apart from components, which are provided with diet, inherent antioxidant compounds including antioxidant enzymes play a crucial role in maintaining oxidative balance. Enzymatic antioxidants are the most potent scavengers of ROS when compared with small molecular weight antioxidants. The importance of antioxidant enzymes in maintaining cell physiology was demonstrated when the intentionally introduced imbalance in their level stimulated different pheno-types. The increase in MnSOD or FeSOD sensitized E. coli cells to paraquat, whereas the increase in CuZnSOD rendered HeLa cells resistant to this compound (Scott et al. 1987; Bloch and Ausubel 1986; Elroy-Stein et al. 1986). In accordance with these findings, the increase in CuZnSOD sensitized mouse epidermal cells JB6 to the formation of DNA strand breaks, the growth inhibition and the cell death in the presence of O2- or H2O2 (Amstad et al. 1991). The compensatory effect was observed when gluta-thione peroxidise was added, indicating that the slight deviations in balance between antioxidant enzymes may influence the oxidation-induced genome instability and cell death. At least three enzymes i.e. superoxide dismutase, catalase, and Gpx, that protect the retina from oxidative damage are present in RPE cells and photoreceptors. The supplementation of low molecular antioxidants may be applied in the treatment of AMD, but it seems that it plays a supportive role and rather alleviates ailments than cures the disease. However, the restoration of function or expression of genes encoding antioxidant enzymes may be much more effective. The treatment based on the re-establishment of antioxidant enzymes balance may be a way to treat AMD. Additionally, the examination of individual genetic predisposition may prevent initiation and progression of AMD as well as serve for treatment purposes.

Superoxide dismutase

SOD catalyzes the dismutation of superoxide into oxygen and H2O2 with catalytic efficiencies near the diffusion limit (McCord and Fridovich 1969; Ragsdale 2009). Since the reaction is limited only by the

frequency of collision between the enzyme and superoxide, thus SOD serves a key antioxidant role. The importance of SOD is manifested by the severe pathologies associated with lack of this enzyme in mouse models (Lee et al. 2013; Kliment et al. 2009; Behndig 2008). There are two major families of superoxide dismutases, depending on metal cofactor: CuZnSOD (SOD1) in cytoplasm and MnSOD (SOD2) in mitochondria in humans (Yu 1994). The role of SOD in the development of AMD is a matter of debate due to the inconsistency of results. Treatment of ARPE-19 cells with acrolein, a potent source of oxidative stress and mitochondrial dysfunction, resulted in a decreased SOD activity as compared with control (Liu et al. 2007; Jia et al. 2007; Feng et al. 2010). The treatment of ARPE-19 cell with a-tocopherol did not influence SOD activity, however, the pre-treatment with this form of vitamin E followed by the subsequent exposure to acrolein led to the protection of SOD activity (Feng et al. 2010). The up-regulation of SOD1/2 expression resulted in oxidative damage in RPE cells as assessed by the measurement of protein carbonyl group content—a marker of protein oxidative damage (Lu et al. 2009). Although the studies conducted in vitro coherently indicate the role of SOD in oxidative stress responses they do not clearly show its association with AMD. The immu-noreactivity of SOD in cytoplasm and lysosomes tended to increase with age in macular RPE cells with and without wet AMD (Frank et al. 1999). However, SOD activity of the RPE periphery tended to decline with age, indicating that the distribution of SOD may change during aging in the retina (De La Paz et al. 1996). An increased level of SOD in serum in AMD patients was demonstrated on two distinct Chinese populations (Shen et al. 2012; Jia et al. 2011). Also, differences were shown in the genotype distribution of the p.Ala9Val polymorphism in the MnSOD gene, which was associated with the level of MnSOD mRNA and protein expression in blood, between patients with AMD and controls (Kowalski et al. 2010). On the other hand, a high level of erythrocyte SOD activity was not associated with AMD in a population-based cross-sectional POLA study (Del-court et al. 1999). However, increase in SOD activity correlated with twofold increase in nuclear cataract. This study is of a special significance since some forms of cataract are associated with the increased risk of AMD (Klein et al. 2012). The most convincing

results confirming the role of SOD in the pathogenesis of AMD come from the report in which the level of SOD was examined in RPE cells obtained from human donors (Liles et al. 1991). In this study, SOD activity showed no significant correlations with aging or AMD.

Glutathione reductase and glutathione peroxidase

Glutathione (GSH) is an antioxidant and participates in H2O2 decomposition, which may be catalysed by selenium-stimulated Gpx. Some studies demonstrated an age-related decrease in plasma GSH, whereas the level of glutathione disulfide (GSSG), oxidised state of GSH, in whole blood increased with age (Samiec et al. 1998; Kretzscharm and Muller 1993; Lang et al. 1992). GSH efflux may contribute to oxidative stress due to GSH depletion. Treatment of RPE cells with a-crystallins (aA and aB, normally present in the retina and serving a protective function) rendered them resistant to oxidant-induced cell death (Sreekumar et al. 2012). This correlated with a twofold increase in the concentration of GSH. On the other hand, a decrease in GSH was observed in cells lacking aA and aB, suggesting a causative role of aA and aB in the regulation of GSH level. High level of GSH may be a consequence of at least two processes: an enhanced GSH biosynthesis and a higher conversion of GSSG to GSH by glutathione reductase. An increase in a-crystallin level accompanied an increase in MRP1 expression—a member of multidrug resistance protein family. MRP1 inhibition decreased GSH efflux, accelerated the intracellular level of GSH and GSSG and made RPE cells resistant to oxidative stress-induced cell death. These results show that the resistance to oxidative stress is executed via a-crystallins-mediated regulation of GSH level. Since it is controlled by glutathione reductase and Gpx, changes in the activity of these enzymes may affect the cellular response to oxidative stress and thus participate in the pathogenesis of AMD. Indeed, blood glutathione reductase activity was lowered in patients with AMD compared with controls (Cohen et al. 1994). Interestingly, Gpx increased activity was found in retinal homogenates of cynomolgus monkeys with early-onset AMD (Nicolas et al. 1996). Additionally, the higher level of plasma Gpx was associated with a nine-fold increase in the prevalence of late AMD, but not early AMD in POLA study conducted on 2,584 subjects (Delcourt et al. 1999). In accordance with

previous results, the illumination of rats with white fluorescent light for 24 h resulted in an increased level of Gpx in the eye as revealed by immunohistochem-istry study (Ohira et al. 2003). Gpx was up-regulated in POS and RPE at the posterior retinal pole whereas the peripheral retina showed a low change in Gpx level. The high expression of Gpx in the RPE was maintained until day 7 after illumination. The Gpx level decreased on day 1 after illumination and was not observed on day 3 or 7 after the light exposure in POS. The increased expression of Gpx1 or Gpx4 reduced the oxidative stress in RPE cells as assessed by the measurement of protein carbonyl group content (Lu et al. 2009). Furthermore, double over-expression of Gpx4 and SOD1 or SOD2 protected RPE cells from oxidative stress generated by the increased level of SOD1 or SOD2. The presence of Gpx4 or Gpx1 reduced the amount of protein carbonyl group in RPE cells treated with oxidative stress-generating factors, including paraquat, H2O2 or hyperoxia. The cells with up-regulated Gpx4 or Gpx1 demonstrated an increased viability against paraquat or H2O2. The up-regulation of Gpx4 protected retinal structure and function in paraquat, H2O2 or hyperoxia models of oxidative-damage-induced retinal degeneration in transgenic mice with inducible expression of Gpx4 in photore-ceptors. Gpx4 was required for regular maturation of photoreceptors in mice (Ueta et al. 2012). Mitochondria were the prime source of Gpx4 expression in wildtype retina. Photoreceptors developed and differentiated regularly until postnatal day 12 and then underwent degeneration and disappeared by postnatal day 21 in mice with Gpx4 knockdown. Therefore, the increase in Gpx activity is associated with AMD. Thus it seems that RPE cells try to dispose of overwhelming amount of H2O2 which is generated in the course of AMD development.

Catalase

Catalase is an iron-dependent enzyme that has two distinct functions—it may act catalytically or peroxid-atively (Chance et al. 1979; Halliwell and Gutteridge 1985). Catalase activity has been shown to decrease in both macular and peripheral RPE during aging (Liles et al. 1991). The immunoreactivity of catalase in cytoplasm and lysosomes showed an age-dependent reduction in macular RPE cells of eyes with and without AMD (Frank et al. 1999). No correlations between

aging and catalase activity (De La Paz et al. 1996) or the expression of catalase mRNA were observed (Miyam-ura et al. 2004). Thus the catalase decline associated with AMD may be age-independent and the catalase activity may be irrespective of its mRNA level suggesting that the AMD-related silencing of catalase activity may be conducted during translation at the earliest. The treatment of RPE cell with ROS-generat-ing compounds stimulated expression of catalase (Tate et al. 1995; Miceli et al. 1994). The inhibition of catalase during ROS uptake increased thiobarbituric acid-reactive substances (TBARS), a byproduct of lipid peroxidation, by 66 % in RPE cells (Miceli et al. 1994). Additionally, the transduction of RPE cells in vitro and in vivo with catalase gene resulted in a protection of transduced cells from H2O2, as well as the adjacent RPE cells or photoreceptors without up-regulated catalase expression (Rex et al. 2004). These results indicate the protective role of catalase against oxidative stress in RPE and neighbouring cells. The presence of ROS-inducing compounds led to a down-regulation of catalase expression at the transcript and protein levels which was accompanied by an enhanced expression of miR-30b, a member of the miR-30 family (Haque et al. 2012). In addition, ROS-generating agents induced transient methylation of the CpG island II in the calatase promoter in hepatocellular carcinoma (HCC) cell line (Min et al. 2010). Furthermore, the treatment of cells with the antioxidant or with the DNA methyl-transferase 1 (DNMT1) inhibitor demethylated the catalase promoter and restored the expression of catalase. The catalase expression and activity was modulated by the level of transcription factor Oct-1, which expression was inhibited through DNA methyl-ation in the presence of ROS (Quan et al. 2011; Tantin et al. 2005). Although these studies were conducted on HCC cells, the mechanism of catalase regulation may be similar in RPE cells. Also the catalase expression was modulated by the acetylation of histone H4 in leukemia cells, indicating that the regulation of catalase expression is a complex and elusive mechanism involving at least three pathways (Lee et al. 2012).

Regulation of antioxidant enzyme expression via microRNA and transcription factors

The study on the role of miRNA in AMD was prompted by the observations that (1) the miRNA

expression pattern differs between AMD patients and individuals without this disease (Kutty et al. 2010) and (2) the administration of synthetic RNA may regulate endogenous miRNA expression and hereby restore the expression pattern of physiological state, arresting or even retreating the development of the disease. Due to these reasons the concern of miRNA in AMD is still growing and may be a potent tool in AMD treatment. miR-30b was over-expressed in ARPE-19 cell under a sublethal dose of oxidative stress (Haque et al. 2012). The administration of the miR-30b antagomir reversed the effect stimulated by the miR-30b mimic— increased the expression of catalase even under oxidant environment. miR-23a, a member of the miR-23 * 27 * 24 cluster, was down-regulated in human RPE cells of AMD patients (Lin et al. 2011). After the H2O2 treatment the level of miR-23a was reduced in RPE cells. The over-expression of miR-23a protected RPE cells from H2O2-induced apoptosis, but had no effect on the cell viability under normal conditions. miR-23a directly targeted Fas—a protein participating in ROS-evoked apoptosis—as shown by the attenuation of H2O2-induced up-regulation of Fas accompanying the over-expression of miR-23a. The expression of Fas and FasL was increased in the photoreceptor and RPE layer of the choroidal neovas-cular membranes from AMD patients (Hinton et al. 1998; Dunaief et al. 2002).

In particular, miRNA processing in the cell may be impaired in AMD interfering with the expression of antioxidant enzymes. In GA—the advanced form of AMD resulting from the death of RPE cells—the miRNA-processing enzyme Dicer1 was depleted in RPE cells (Kaneko et al. 2011). The down-regulation of Dicer1 resulted in the degeneration of RPE cells in mice. This effect was not observed for other miRNA-processing enzymes, including Drosha, DGCR8 or Ago2. The knockdown of Dicer1 induced the accumulation of cytotoxic Alu RNA. Interestingly, the level of Alu RNA was increased in GA patients. The treatment with antisense inhibitor of Alu RNA prevented Dicer1 down-regulation, which correlated with Dicer1-mediated degradation of Alu RNA in humans and prevented RPE degradation in mice. Recent findings, carried out on animal models, indicated a role of endoplasmic reticulum (ER) stress in the retinal degeneration accompanied by oxidative stress and death of photoreceptors (Lin et al. 2007; Yang et al. 2007, 2008). XBP1 is a transcription factor

regulating ER stress. Its down-regulation enhanced the photoreceptor degradation in Drosophila model for autosomal dominant retinitis pigmentosa (Ryoo et al. 2007). The activity of XBP1 was reduced in RPE cells with a light-induced retinal degeneration in vivo (Zhong et al. 2012). The siRNA-mediated knockdown of XBP1 correlated with the decreased expression of SOD1, SOD2, catalase and glutathione synthase along with the increased susceptibility of RPE cells to oxidative damage (Zhong et al. 2012). The expression of SOD1, SOD2 and catalase was reduced in the RPE cells deprived of XBP1 and accompanied by the increase in oxidative stress in the mouse line in comparison with wild type counterparts. The RPE cell death reduced the number of cone photoreceptors and the thickening of outer nuclear layer and Bruch's membrane, shortened POS as well as decreased retinal function in the XPB1-lacking mice.

The response of cells to oxidative stress may include the activation of genes with the antioxidant responsive element (ARE) via the transcription factor Nrf2 (NF-E2-related factor 2) (Lee et al. 2003a). ARE is a cis-acting regulatory element of genes encoding phase II detoxification enzymes and antioxidant proteins, such as NAD(P)H quinine oxidoreductase 1 (NQO1), glutathione S-transferases (GST) and gluta-mate-cysteine ligase (GCL) (Lee et al. 2003a). The function of Nrf2 and the subsequent activation of its target genes were shown to play an important role in cell protection against oxidative stress. Nrf2 is a ubiquitous protein, expressed in numerous cell types regulating a battery of ARE-dependent genes (Lee et al. 2003a, b; Shih et al. 2003; Chen et al. 2009b). The activation of Nrf2 is conducted via electrophiles and oxidants which modify critical cysteine thiols of Keap1 (Kelch-like erythroid cell-derived protein with CNC homology-associated protein 1) thus preventing the Nrf2 ubiquitination and degradation. The Nrf2 over-expression was protective against toxic pheno-type caused by the dominant mutation in SOD1 in astrocytes (Vargas et al. 2008). Therefore, it may be speculated that increasing the Nrf2 concentration may be beneficial in diseases associated with SOD dysfunction, including AMD. This suggests a dominant role of the regulation of oxidative stress induced genes either via miRNA or transcription factors, which may further serve for AMD treatment purposes. Also other mechanisms cannot be excluded in this regard. The advantage of gene expression based therapy is its

extensive efficiency resulting from the opportunity of targeting multiple genes of one metabolic pathway.

Autophagy is a conserved lysosomal pathway responsible for the turnover of malfunctioning proteins in eukaryotic cells. The accumulation of long-lived proteins, excess or damaged organelles, and aggregation-prone proteins may be particularly detrimental in the post-mitotic cells such as RPE. The pathogenesis of AMD involves the impairment of protein degradation in RPE cells. The p62/SQSTM1 protein recognizes toxic cellular waste, which is directed to autophagy. The loss of autophagy caused p62 accumulation and the induction of antioxidant proteins including NQO1 and GSTs in mice (Komatsu et al. 2007, 2010). Thus it seems that p62 may be a key inducer of Nrf2 target genes. The p62 bound to Keap1 in a pocket overlapping with the binding pocket for Nrf2. The excess of p62 prevented Nrf2 binding to Keap1 and thus also Nrf2 ubiquitination resulting in the activation of Nrf2 and induction of ARE-dependent genes (Jain et al. 2010; Komatsu et al. 2010; Lau et al. 2010). The deregulation of Nrf2-Keap1 binding may play a role in autophagy-related pathologic conditions as it was shown in mice in which loss of Nrf2 decreased but loss of Keap1 intensified the liver injury observed in autophagy-deficient mice. The p62 is over-expressed in many neurodegenerative diseases such as in Parkinson, Alzheimer, and Huntington's diseases (Kuusisto et al. 2001, 2002; Nagaoka et al. 2004; Zatloukal et al. 2002). Interestingly, several proteins identified in the deposits occurring in Alzheimer disease have also been found in eye samples isolated from patients with AMD (Mullins et al. 2000). In addition, knockdown of p62 suppressed autophagy in ARPE-19 cells revealing its important role in proteolysis (Viiri et al. 2010).

Although AMD is not considered a classic inflammatory disease, the pathogenic role of immunologic processes in the occurrence and progression of AMD is experimentally and clinically documented. Correlations between immunological/inflammatory gene polymorphisms and AMD indicate the involvement of inflammation and immune-mediated processes (complement activation) in the pathogenesis of this disease (Bergeron-Sawitzke et al. 2009; Ryu et al. 2010). Furthermore, immunocompetent cells, such as macrophages and lymphocytes, were present in the chorioretinal tissues affected by AMD (Penfold et al. 1985; Lopez et al. 1991). Also, the complement

pathway was deregulated in eyes from AMD patients. It was demonstrated that oxidative damage induced inflammation and initiated formation of AMD-like lesions, including drusen accumulation below the RPE upon aging, development of lesions mimicking geographic atrophy in RPE and the blindness in mice, indicating a direct link between oxidative damage and inflammatory response in AMD (Hollyfield et al. 2008). Thus, it may be expected that modulation of the level of oxidative damage may influence the inflammatory response. Also, the reverse relationship showing the stimulation of antioxidant enzyme activity upon administration of acute inflammatory response inductor, endotoxin, in the rabbit eye was manifested (Recasens and Green 1992). Endotoxin administration was associated with a significant SOD induction in choroids and retinas of adult animals but not of aged animals. This effect suggests vulnerability of ocular tissues from aged animals to inflammation-related oxidative stress due to their inability to induce SOD in response to inflammatory stimulus.

Genetic variability in antioxidant enzymes in AMD

There is a growing body of evidence that oxidative stress may contribute to the initiation and progression of AMD. It is believed that the degeneration of RPE cells is an early event in the pathogenic process leading to AMD. Certain factors affecting RPE cells may render them especially susceptible to oxidative damage. These factors include deficiency in low molecular weight antioxidants, DNA repair and antioxidant enzymes (Fig. 1). In the case of antioxidant enzymes and DNA repair enzymes, their dysfunction cannot be easily reversed. It seems that antioxidant enzymes play a first line of defence against oxidative injury, thus the re-establishment of their balance in cell may be a priority. The application of compounds functioning as enhancers of the antioxidant enzymes expression or activity may constitute a class of potential drugs. The protective effect of compounds on ARPE-19 against t-BH-stimulated oxidative stress was reported for phenol derivative—canonol (Dong et al. 2011). Canonol showed virtually no cytotoxicity, inhibited the t-BH-induced intracellular ROS generation and the ARPE-19 cells death and enhanced the expression of a number of genes encoding antioxidant enzymes, including catalase and glutathione S-transferase-pi (GST-pi). Genetic variability and mutations occurring

in DNA sequence encoding antioxidant enzymes may influence the activity and structure of these enzymes, and even the sensitivity of patients to drugs or supplements. The study on the genetic polymorphism Pro198Leu and the variability on alanine repeat codons in the Gpx-1 gene in human lymphoblast cell lines showed a significant variability in the sensitivity of the cells to selenium supplementation (Zhuo et al. 2009). In response to selenium, all human lymphoblast cell lines showed increase in the activity of Gpx ranging from 1.3 to 6.9fold. Allelic variation in alanine repeat codons of Gpx-1 had an influence on the Gpx-1 thermostability and selenium supplementation changed this parameter depending on the haplotype of the cell line. A C to T substitution at the -9 position in the mitochondrial targeting sequence of the MnSOD gene (V16A, rs4880) was associated with the exudative form of AMD in Japanese population (Kimura et al. 2000). This polymorphism resulted in a more efficient transport of MnSOD into the mitochondria and in a higher basal activity of MnSOD, which led to the excessive hydrogen peroxide production. However, this initially reported association was not replicated by other groups (Gotoh et al. 2008; Kondo et al. 2009). However, the p.Ala9Val polymorphism in the MnSOD gene was associated with the level of mRNA and protein expression in humans (Kowalski et al. 2010). The Ala9Ala genotype and the alanine allele were more frequent in AMD patients than in healthy subjects. Healthy controls that are homozygotes Val/Val and heterozygotes Ala/Val showed lower expression of MnSOD gene as compared to homozygote Ala/Ala. The lowest expression of MnSOD was noted in homozygotes Val/Val in wet AMD and heterozygotes Ala/Val in its dry form. The multiple analysis of polymorphic sites in the MnSOD (rs1799725, rs2758330, rs1967802), CAT (rs480575, rs1408035, rs769217, rs2284367) and Gpx1 (rs3448, rs3811699) genes conducted on a Northern Irish population showed no significant association with AMD (Esfandiary et al. 2005). Thus, these results manifest the need for further studies concerning polymorphic variability in antioxi-dant enzymes genes, which may serve as a predictive tool and target for AMD personal therapy.

The treatment/prophylaxis of AMD with vitamins, minerals and enzymatic antioxidants

Antioxidant supplementation has provided promising results slowing down AMD progression and preventing

AMD occurrence indicating its clinical potential. The AREDS study demonstrated that daily oral supplementation with antioxidant vitamins and minerals reduced the risk of developing advanced AMD by 25 % after 5 years (Age-Related Eye Disease Study Research Group 2001). AREDS formulation including zinc (80 mg), vitamin C (500 mg), vitamin E (400 IU), p-carotene (15 mg) and copper (2 mg) has become the major nutritional support for AMD treatment and is routinely recommended to patients being at a high risk of developing advanced AMD in the US (Kowluru and Zhong 2011). Copper is included into AREDS formulation in order to prevent copper deficiency anemia, a condition associated with high levels of zinc intake (Age-Related Eye Disease Study Research Group 2001). Despite that achieving the levels of vitamins and minerals provided in AREDS formulation is difficult with diet alone, diet rich in vegetables lowered the risk of developing AMD (Sommerburg et al. 1998; Seddon et al. 1994). Although no side effects were demonstrated from antioxidant dietary supplementation, they were present in patients taking AREDS formulation indicating that the intake of AREDS formulation has to be preceded with medial consultation and thoughtful consideration. These side effects included (1) minor, clinically non-relevant inconve-nience—the skin yellowing due to high intake of p-carotene, (2) serious medical problem associated with the urinary tract due to zinc treatment and (3) severe disorders such as higher risk of occurring p-carotene-associated lung cancer in smokers (Age-Related Eye Disease Study Research Group 2001; Age-Related Eye Disease Study 2 Research Group 2013). Although some data suggest that increased dietary intake of long-chain PUFAs reduces the risk of advanced AMD, however, the addition of lutein/zeaxanthin (carotenoids), omega-3 long-chain PUFAs (DHA and EPA), or both to AREDS formulation did not evoke a significant reduction in progression to advanced AMD (Chong et al. 2008; SanGiovanni et al. 2007; Age-Related Eye Disease Study 2 Research Group 2013). However, lutein/zeaxanthin could constitute an appropriate substitute for p-carotene, which is associated with increased incidence of lung cancer in smokers. Apart from vitamins and minerals, antioxidant enzymes-based therapy seems to be a promise for diseases associated with increased ROS production. Although not yet studied in AMD, promising results obtained from other ROS-associated diseases suggest their

potential for AMD treatment. This approach is still in its early stage, struggling with preserving the activity of enzymes and directing enzymes to the target side. This strategy is currently under investigation for treatment of different ROS-associated diseases including atherosclerosis, hypertension, heart failure, diabetes mellitus using extracellular superoxide dismutase (EC-SOD) (Maksimenko and Vavaev 2012). Also, covalent conjugate SOD-CHS-CAT (CHS, chondroitin sulphate) which showed high efficacy and safety is a promising drug candidate (Maksimenko et al. 2004). Although the antioxidant enzymes preserve their activities in vitro there are still problems with their delivery minimizing the risk of proteolysis. New approach exploiting the non-polymeric magnetic nanoparticles as the antioxi-dant enzymes carrier was successful in endothelial delivery of SOD and catalase preserving their biological activity (Chorny et al. 2010). The antioxidant enzyme-oriented treatment includes also genetic therapy which was proved efficient for genetic transfer of EC-SOD, which ameliorated endothelium function and decreased the arterial pressure in spontaneously hypertensive rats (Chu et al. 2003). The global regulation of the epigenome, which might enhance oxidative stress resistance, is an attractive approach to AMD treatment. Indeed, the synthetic peptide induced the expression of genes repressed due to age-related condensation of euchromatic chromosome regions in people aged 76-80 years (Khavinson et al. 2003). The traditional antioxidant-rich nutrition along with additional antiox-idant supplementation supported with new antioxidant enzymes delivery approach seems to be a promising treatment perspective in future.

Conclusions and future perspectives

AMD is a complex, degenerative and progressive eye disease that usually does not lead to complete blindness but can result in severe loss of central vision. All AMD risk factors such as age, genetics, diet, smoking, oxidative stress and many cardiovascular associated risk factors involve increased ROS production. Therefore, effective ROS scavenging may be essential for preventing AMD. Initial successes with diet supplementation with small molecular weight antioxidants in the AREDS study prompt for considering other elements of antioxidant defence as possible targets in AMD prevention and future therapy. The activity of

antioxidant enzymes, the main component of antioxidant defence, depends on the sequence of their genes and their epigenetic profile. Therefore, determination of the genotype of these genes in individuals at AMD risk, may have diagnostic and prognostic significance. Also drugs modifying epigenetic pattern of these genes may be considered in AMD prevention. Such kind of drugs were approved for treatment of some cancers. Manipulating in the sequence of these genes by gene therapy may be considered in extreme cases to prevent progression of AMD, but it seems unlikely that this might reverse pathological changes associated with the disease.

Acknowledgments This work was supported by the EVO grants of Kuopio University Hospital, the Finnish Cultural Foundation and its North Savo Fund, the Finnish Eye Foundation, the Finnish Funding Agency for Technology and Innovation, Health Research Council of the Academy of Finland, and the Paivikki and Sakari Sohlberg Foundation.

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

References

Agency for Toxic Substances and Disease Registry (ATSDR) (2005) CERCLA priority list of hazardous substances. Available at: http://www.atsdr.cdc.gov/cxcx3. html. Accessed 10 Aug 2013 Age-Related Eye Disease Study 2 Research Group (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (AREDS2) randomized clinical trial. JAMA 309:2005-2015

Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417-1436 Amstad P, Peskin A, Shah G, Mirault ME, Moret R, Zbinden I, Cerutti P (1991) The balance between Cu, Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 30:9305-9313 Anderson SM, Krinsky NI (1973) Protective action of caroten-oid pigments against photodynamic damage to liposomes. Photochem Photobiol 18:403-408 Anderson RE, Benolken RM, Dudley PA, Landis DJ, Wheeler TG (1974) Proceedings: polyunsaturated fatty acids of photoreceptor membranes. Exp Eye Res 18:205-213 Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 13:411-431

Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV (2004) Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res 78:243-256 Arstila AU, Smith MA, Trump BF (1972) Microsomal lipid peroxidation: morphological characterization. Science 175:530-533

Ballinger SW, Van Houten B, Jin GF, Conklin CA, Godley BF (1999) Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp Eye Res 68:765-772 Bannon DI, Abounader R, Lees PS, Bressler JP (2003) Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells. Am J Physiol Cell Physiol 284:C44-C50 Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age related macular degeneration. Br J Ophthalmol 83:867-877 Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115-134 Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439-446 Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR (2013) Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology 120:600-606 Behndig A (2008) Corneal endothelial integrity in aging mice lacking superoxide dismutase-1 and/or superoxide dismu-tase-3. Mol Vis 14:2025-2030 Bergeron-Sawitzke J, Gold B, Olsh A, Schlotterbeck S, Lemon K, Visvanathan K, Allikmets R, Dean M (2009) Multilocus analysis of age-related macular degeneration. Eur J Hum Genet 17:1190-1199 Bernstein PS, Ahmed F, Liu A, Allman S, Sheng X, Sharifzadeh M, Ermakov I, Gellermann W (2012) Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center. Invest Ophthalmol Vis Sci 53:6178-6186 Bhutto I, Lutty G (2012) Understanding age-related macular degeneration (AMD): relationships between the photore-ceptor/retinal pigment epithelium/Bruch's membrane/ choriocapillaris complex. Mol Aspects Med 33:295-317 Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R (1995) International classification and grading system for age-related maculopathy and age-related degeneration. Surv Ophthalmol 39:367-374 Blasiak J, Glowacki S, Kauppinen A, Kaarniranta K (2013) Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration. Int J Mol Sci 14:2996-3010 Bloch CA, Ausubel FM (1986) Paraquat-mediated selection for mutations in the manganese-superoxide dismutase gene sodA. J Bacteriol 168:795-798 Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular pigment. Vision Res 25:1531-1535

Bone RA, Landrum JT, Fernandez L, Tarsis SL (1988) Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 29:843-849

Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilburn MD, Menendez E, Vidal I, Wang W (1997) Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 64:211-218 Boulton M (1998) The role of melanin in the RPE. In: Marmor MF, Wolfensberger TJ (eds) The retinal pigment epithelium. Oxford University Press, Oxford, pp 68-85 Bush RA, Reme CE, Malnoe A (1991) Light damage in the rat retina: the effect of dietary deprivation of N-3 fatty acids on acute structural alterations. Exp Eye Res 53:741-752 Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP (2000) Oxidative damage and protection of the RPE. Prog Retin Eye Res 19:205-221 Chalam KV, Khetpal V, Rusovici R, Balaiya S (2011) A review: role of ultraviolet radiation in age-related macular degeneration. Eye Contact Lens 37:225-232 Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism

in mammalian organs. Physiol Rev 59:527-605 Chen H, Lukas TJ, Du N, Suyeoka G, Neufeld AH (2009a) Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity. Invest Ophthalmol Vis Sci 50:1895-1902 Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA (2009b) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc Natl Acad Sci USA 106: 2933-2938

Chiba Y, Shimada A, Kumagai N, Yoshikawa K, Ishii S, Furukawa A, Takei S, Sakura M, Kawamura N, Hosokawa M (2009) The senescence-accelerated mouse (SAM): a higher oxidative stress and age-dependent degenerative diseases model. Neurochem Res 34:679-687 Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH (2008) Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 126:826-833

Chorny M, Hood E, Levy RJ, Muzykantov VR (2010) Endo-thelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles. J Control Release 146:144-151

Christen WG, Glynn RJ, Sesso HD, Kurth T, Macfadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM (2012) Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians. Ophthalmology 119:1642-1649 Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, Faraci FM, Heistad DD (2003) Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 92:461-468 Cohen SM, Olin KL, Feuer WJ, Hjelmeland L, Keen CL, Morse LS (1994) Low glutathione reductase and peroxidase activity in age-related macular degeneration. Br J Oph-thalmol 78:791-794 Cui H, Kong Y, Zhang H (2012) Oxidative stress, mitochondrial

dysfunction, and aging. J Signal Transduct 2012:646354 De La Paz M, Anderson RE (1992) Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci 33:3497-3499

De La Paz MA, Zhang J, Fridovich I (1996) Antioxidant enzymes of the human retina: effect of age on enzyme activity of macula and periphery. CurrEye Res 15:273-278 Del Priore LV, Kuo YH, Tezel TH (2002) Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci 43:3312-3318 Delcourt C, Cristol JP, Leger CL, Descomps B, Papoz L (1999) Associations of antioxidant enzymes with cataract and age-related macular degeneration. The POLA study. Pathologies Oculaires Liees a l'Age. Ophthalmology 106:215-222

Delcourt C, Carriere I, Delage M, Barberger-Gateau P, Schalch W (2006) Plasma lutein and zeaxanthin and other carote-noids as modifiable risk factors for age-related maculopa-thy and cataract: the POLA study. Invest Ophthalmol Vis Sci 47:2329-2335 Deleon E, Lederman M, Berenstein E, Meir T, Chevion M, Chowers I (2009) Alteration in iron metabolism during retinal degeneration in rd10 mouse. Invest Ophthalmol Vis Sci 50:1360-1365 Delori FC, Goger DG, Dorey CK (2001) Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 42:1855-1866 Desler C, Marcker ML, Singh KK, Rasmussen LJ (2011) The importance of mitochondrial DNA in aging and cancer. J Aging Res 2011:407536 Dong X, Li Z, Wang W, Zhang W, Liu S, Zhang X (2011) Protective effect of canolol from oxidative stress-induced cell damage in ARPE-19 cells via an ERK mediated anti-oxidative pathway. Mol Vis 17:2040-2048 Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ (1989) Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci 30:1691-1699 Dunaief JL, Dentchev T, Ying GS, Milam AH (2002) The role of apoptosis in age-related macular degeneration. Arch Ophthalmol 120:1435-1442 Edge R, McGarvey DJ, Truscott TG (1997) The carotenoids as anti-oxidants—a review. J Photochem Photobiol B 41: 189-200

Elroy-Stein O, Bernstein Y, Groner Y (1986) Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J 5:615-622 Erie JC, Good JA, Butz JA, Pulido JS (2009) Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration. Am J Ophthalmol 147:276-282 Esfandiary H, Chakravarthy U, Patterson C, Young I, Hughes AE (2005) Association study of detoxification genes in age related macular degeneration. Br J Ophthalmol 89:470-474 Eye Disease Case-Control Study Group (1993) Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 111:104-109 Farnsworth CC, Stone WL, Dratz EA (1979) Effects of vitamin E and selenium deficiency on the fatty acid composition of rat retinal tissues. Biochim Biophys Acta 552:281-293 Feeney-Burns L, Hilderbrand ES, Eldridge S (1984) Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells. Invest Ophthalmol Vis Sci 25: 195-200

Feng Z, Liu Z, Li X, Jia H, Sun L, Tian C, Jia L, Liu J (2010) a-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. J Nutr Biochem 21:1222-1231 Fine SL, Berger JW, Maguire MG, Ho AC (2000) Age-related

macular degeneration. New Engl J Med 342:483-492 Foote CS, Denny RW (1968) Chemistry of singet oxygen. VII

Quenching by -carotene. J Am Chem Soc 90:6233-6235 Frank RN (1997) Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res 29:341-353 Frank RN, Amin RH, Puklin JE (1999) Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neo-vascular age-related macular degeneration. Am J Oph-thalmol 127:694-709 Friedrichson T, Kalbach HL, Buck P, van Kuijk FJ (1995) Vitamin E in macular and peripheral tissues of the human eye. Curr Eye Res 14:693-701 Girijashanker K, He L, Soleimani M, Reed JM, Li H, Liu Z, Wang B, Dalton TP, Nebert DW (2008) Slc39a14 gene encodes ZIP14, a metal/bicarbonatesymporter: similarities to the ZIP8 transporter. Mol Pharmacol 73:1413-1423 Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO (1988) Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 128: 700-710

Gotoh N, Yamada R, Matsuda F, Yoshimura N, Iida T (2008) Manganese superoxide dismutase gene (SOD2) polymorphism and exudative age-related macular degeneration in the Japanese population. Am J Ophthalmol 146:146-147 Haegerstrom-Portnoy G (1988) Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment? J Opt Soc Am A 5:2140-2144 Halliwell B, Gutteridge JM (1985) The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med 8:89-193 Ham WT Jr, Ruffolo JJ Jr, Mueller HA, Clarke AM, Moon ME (1978) Histologic analysis of photochemical lesions produced in rhesus retina by short-wave-length light. Invest Ophthalmol Vis Sci 17:1029-1035 Haque R, Chun E, Howell JC, Sengupta T, Chen D, Kim H (2012) MicroRNA-30b-mediated regulation of catalase expression in human ARPE-19 cells. PLoS ONE 7:e42542 Harman D (1956) Aging: a theory based on free radical and

radiation chemistry. J Gerontol 11:298-300 Hayes KC (1978) Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. Invest Ophthalmol Vis Sci 13:499-510

He L, Girijashanker K, Dalton TP, Reed J, Li H, Soleimani M, Nebert DW (2006) ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol Pharmacol 70:171-180 He Y, Ge J, Burke JM, Myers RL, Dong ZZ, Tombran-Tink J (2010) Mitochondria impairment correlates with increased sensitivity of aging RPE cells to oxidative stress. J Ocul Biol Dis Inform 3:92-108 Hinton DR, He S, Lopez PF (1998) Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch Ophthalmol 116:203-209

Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, Ufret RL, Salomon RG, Perez VL (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 14:194-198 Holz FG, Schutt F, Kopitz J, Eldred GE, Kruse FE, Volcker HE, Cantz M (1999) Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipo-fuscin. Invest Ophthalmol Vis Sci 40:737-743 Hunter JJ, Morgan JI, Merigan WH, Sliney DH, Sparrow JR, Williams DR (2012) The susceptibility of the retina to photochemical damage from visible light. Prog Retin Eye Res 31:28-42

Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Umezawa K, Ohno S, Oike Y, Ishida S (2007) Macular pigment lutein is antiinflammatory in preventing choroidal neovascularisation. Arterioscler Thromb Vasc Biol 27:2555-2562 Jain A, Lamark T, Sj0ttem E, Larsen KB, Awuh JA, 0vervatn A, McMahon M, Hayes JD, Johansen T (2010) p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285:22576-22591 Jia L, Liu Z, Sun L, Miller SS, Ames BN, Cotman CW, Liu J (2007) Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid. Invest Ophthal-mol Vis Sci 48:339-348 Jia L, Dong Y, Yang H, Pan X, Fan R, Zhai L (2011) Serum superoxide dismutase and malondialdehyde levels in a group of Chinese patients with age-related macular degeneration. Aging Clin Exp Res 23:264-267 Jiang C, Ganther H, Lu J (2000) Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation. Mol Carcinog 29:236-250 Jin GF, Hurst JS, Godley BF (2001) Rod outer segments mediate mitochondrial DNA damage and apoptosis in human retinal pigment epithelium. Curr Eye Res 23:11-19 Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH (2000) A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 70:441-449 Jorgensen K, Skibsted LH (1993) Carotenoid scavenging of radicals. Effect of carotenoid structure and oxygen partial pressure on antioxidative activity. Z Lebensm Unters Forsch 196:423-429 Julien S, Biesemeier A, Kokkinou D, Eibl O, Schraermeyer U (2011) Zinc deficiency leads to lipofuscin accumulation in the retinal pigment epithelium of pigmented rats. PLoS ONE 6:e29245

Jünemann AG, Stopa P, Michalke B, Chaudhri A, Reulbach U, Huchzermeyer C, Schlotzer-Schrehardt U, Kruse FE, Zrenner E, Rejdak R (2013) Levels of aqueous humor trace elements in patients with non-exsudative age-related macular degeneration: a case-control study. PLoS ONE 8:e56734

Junghans A, Sies H, Stahl W (2001) Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 391:160-164 Justilien V, Pang JJ, Renganathan K, Zhan X, Crabb JW, Kim SR, Sparrow JR, Hauswirth WW, Lewin AS (2007) SOD2 knockdown mouse model of early AMD. Invest Ophthal-mol Vis Sci 48:4407-4420

Kaarniranta K, Salminen A, Haapasalo A, Soininen H, Hiltunen M (2011) Age-related macular degeneration (AMD): Alzheimer's disease in the eye? J Alzheimers Dis 24:615-631 Kaarniranta K, Sinha D, Blasiak J, Kauppinen A, Vereb Z, Salminen A, Boulton ME, Petrovski G (2013) Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy 9(7):973-984 Kamei M, Yoneda K, Kume N, Suzuki M, Itabe H, Matsuda K, Shimaoka T, Minami M, Yonehara S, Kita T, Kinoshita S (2007) Scavenger receptors for oxidised lipoprotein in age-related macular degeneration. Invest Ophthalmol Vis Sci 48:1801-1807

Kaneko H, Dridi S, Tarallo V, Gelfand BD, Fowler BJ, Cho WG, Kleinman ME, Ponicsan SL, Hauswirth WW, Chiodo VA, Kariko K, Yoo JW, Lee DK, Hadziahmetovic M, Song Y, Misra S, Chaudhuri G, Buaas FW, Braun RE, Hinton DR, Zhang Q, Grossniklaus HE, Provis JM, Madigan MC, Milam AH, Justice NL, Albuquerque RJ, Blandford AD, Bogdanovich S, Hirano Y, Witta J, Fuchs E, Littman DR, Ambati BK, Rudin CM, Chong MM, Provost P, Kugel JF, Goodrich JA, Dunaief JL, Baffi JZ, Ambati J (2011) DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471:325-330 Khavinson VKh, Lezhava TA, Monaselidze JR, Jokhadze TA, Dvalishvili NA, Bablishvili NK, Trofimova SV (2003) Peptide Epitalon activates chromatin at the old age. Neuro Endocrinol Lett 24:329-333 Kijlstra A, La Heij EC, Hendrikse F (2005) Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocul Immunol Inflamm 13:3-11 Kijlstra A, Tian Y, Kelly ER, Berendschot TT (2012) Lutein: more than just a filter for blue light. Prog Retin Eye Res 31:303-315

Kim JH, Na H, Kim CK, Kim JY, Ha KS, Lee H, Chung HT, Kwon HJ, Kwon YG, Kim YM (2008) The non-provitarnin A carotenoid, lutein, inhibits NF-kappa B-dependent gene expression through redox-based regulation of the phos-phatidylinositol 3-kinase/PTEN/Akt and NF-kappa B-inducing kinase pathways: role of H2O2 in NF-kappa B activation. Free Radic Biol Med 45:885-896 Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N (2000) Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130:769-773 Klein LR, MacLeish PR, Wiesel TN (1990) Immunolabelling by a newt retinal pigment epithelium antibody during retinal development and regeneration. J Comp Neurol 293: 331-339

Klein BE, Howard KP, Lee KE, Iyengar SK, Sivakumaran TA, Klein R (2012) The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 119:1628-1633 Kliment CR, Suliman HB, Tobolewski JM, Reynolds CM, Day BJ, Zhu X, McTiernan CF, McGaffin KR, Piantadosi CA, Oury TD (2009) Extracellular superoxide dismutase regulates cardiac function and fibrosis. J Mol Cell Cardiol 47:730-742

Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J,

Warabi E, Yoshida H, Ishii T, Kobayashi A, Yamamoto M, Yue Z, Uchiyama Y, Kominami E, Tanaka K (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149-1163

Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12:213-223 Kondo N, Bessho H, Honda S, Negi A (2009) SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis 15:1819-1826 Kowalski M, Bielecka-Kowalska A, Oszajca K, Eusebio M, Jaworski P, Bartkowiak J, Szemraj J (2010) Manganese superoxide dismutase (MnSOD) gene (Ala-9Val, Ile58Thr) polymorphism in patients with age-related macular degeneration (AMD). Med Sci Monit 16:CR190-CR196 Kowluru RA, Zhong Q (2011) Beyond AREDS: is there aplace for antioxidant therapy in the prevention/treatment of eye disease? Invest Ophthalmol Vis Sci 52:8665-8671 Kretzscharm M, Muller D (1993) Aging, training and exercise. A review of effects on plasma glutathione and lipid peroxides. Sports Med 10:196-209 Krinsky NI, Deneke SM (1982) Interaction of oxygen and oxy-radicals with carotenoids. J Natl Cancer Inst 69:205-210 Kritchevsky SB, Bush AJ, Pahor M, Gross MD (2000) Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol 152:1065-1071 Krohne TU, Stratmann NK, Kopitz J, Holz FG (2010) Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Exp Eye Res 90:465-471 Kutty RK, Samuel W, Jaworski C, Duncan T, Nagineni CN, Raghavachari N, Wiggert B, Redmond TM (2010) Micr-oRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl) retinamide. Mol Vis 16:1475-1486 Kuusisto E, Salminen A, Alafuzoff I (2001) Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. NeuroReport 12:2085-2090

Kuusisto E, Salminen A, Alafuzoff I (2002) Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathol Appl Neu-robiol 28:228-237 Lam S, Tso MO, Gurne DH (1990) Amelioration of retinal photic injury in albino rats by dimethylthiourea. Arch Ophthalmol 108:1751-1757 Landrum JT, Bone RA (2001) Lutein, zeaxanthin, and macular

pigment. Arch Biochem Biophys 385:28-40 Lang CA, Naryshkin S, Schneider DL, Mills BJ, Lindeman R (1992) Low blood glutathione levels in healthy aging adults. J Lab Clin Med 120:720-725 Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T, Jiang T, Sun Z, White E, Zhang DD (2010) A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol 30:3275-3285

Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA (2003a) Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide micro-array analysis. J Biol Chem 278:12029-12038 Lee JM, Shih AY, Murphy TH, Johnson JA (2003b) NF-E2-related factor-2 mediates neuroprotection against mito-chondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem 278:37948-37956 Lee TB, Moon YS, Choi CH (2012) Histone H4 deacetylation down-regulates catalase gene expression in doxorubicin-resistant AML subline. Cell Biol Toxicol 28:11-18 Lee YS, Cheon IS, Kim BH, Kwon MJ, Lee HW, Kim TY (2013) Loss of extracellular superoxide dismutase induces severe IL-23-mediated skin inflammation in mice. J Invest Dermatol 133:732-741 Liles MR, Newsome DA, Oliver PD (1991) Antioxidant enzymes in the aging human retinal pigment epithelium. Arch Ophthalmol 109:1285-1288 Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, Walter P (2007) IRE1 signaling affects cell fate during the unfolded protein response. Science 318:944-949 Lin H, Qian J, Castillo AC, Long B, Keyes KT, Chen G, Ye Y (2011) Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 52:6308-6314 Liu Z, Sun L, Zhu L, Jia X, Li X, Jia H, Wang Y, Weber P, Long J, Liu J (2007) Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J Neurochem 103:2690-2700 Lopez PF, Grossniklaus HE, Lambert HM, Aaberg TM, Capone A Jr, Sternberg P Jr, L'Hernault N (1991) Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 112:647-656 Lu L, Hackett SF, Mincey A, Lai H, Campochiaro PA (2006) Effects of different types of oxidative stress in RPE cells. J Cell Physiol 206:119-125 Lu L, Oveson BC, Jo YJ, Lauer TW, Usui S, Komeima K, Xie B, Campochiaro PA (2009) Increased expression of glutathi-one peroxidase 4 strongly protects retina from oxidative damage. Antioxid Redox Signal 11:715-724 Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, Lu-ong V, Fitzke FW, Bainbridge JW, Ali RR, MacLaren RE (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthal-mol Vis Sci 50:5934-5943 Macular Degeneration Association (2013) Available at http://

maculardegenerationassociation.org/ Majji AB, Cao J, Chang KY, Hayashi A, Aggarwal S, Grebe RR, De Juan E (2000) Age-related retinal pigment epithelium and Bruch's membrane degeneration in senescence-accelerated mouse. Invest Ophthalmol Vis Sci 41:3936-3942 Maksimenko AV, Vavaev AV (2012) Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress. Heart Int 7:e3

Maksimenko AV, Golubykh VL, Tischenko EG (2004) The combination of modified antioxidant enzymes for anti-thrombotic protection of the vascular wall: the significance of covalent connection of superoxide dismutase and cata-lase activities. J Pharm Pharmacol 56:1463-1468 Mares-Perlman JA, Brady WE, Klein R, Klein BE, Bowen P, Stacewicz-Sapuntzakis M, Palta M (1995) Serum antioxi-dants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 113: 1518-1523

Martin P, Fareh M, Poggi MC, Boulukos KE, Pognonec P (2006) Manganese is highly effective in protecting cells from cadmium intoxication. Biochem Biophys Res Commun 351:294-299 McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055 Miceli MV, Liles MR, Newsome DA (1994) Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp Cell Res 214:242-249 Min JY, Lim SO, Jung G (2010) Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett 584:2427-2432 Miyamura N, Ogawa T, Boylan S, Morse LS, Handa JT, Hjelmeland LM (2004) Topographic and age-dependent expression of heme oxygenase-1 and catalase in the human retinal pigment epithelium. Invest Ophthalmol Vis Sci 45:1562-1565

Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amy-loidosis, and dense deposit disease. FASEB J 14:835-846 Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K, Oyama F, Nukina N (2004) Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J Neurochem 91: 57-68

National Eye Institute (2013) Available at http://www.nei.nih.

gov/. Accessed 10 Aug 2013 Newsome DA, Swartz M, Leone NC, Elston RC, Miller E (1988) Oral zinc in macular degeneration. Arch Ophthal-mol 106:192-198 Nicolas MG, Fujiki K, Murayama K, Suzuki MT, Shindo N, Hotta Y, Iwata F, Fujimura T, Yoshikawa Y, Cho F, Kanai A (1996) Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress. Exp Eye Res 62:399-408 Ohira A, Tanito M, Kaidzu S, Kondo T (2003) Glutathione peroxidase induced in rat retinas to counteract photic injury. Invest Ophthalmol Vis Sci 44:1230-1236 Organisciak DT, Winkler BS (1994) Retinal light damage: practical and theoretical considerations. Prog Retin Eye Res 13:1-29

Organisciak DT, Wang HM, Li ZY, Tso MO (1985) The protective effect of ascorbate in retinal light damage of rats. Invest Ophthalmol Vis Sci 26:1580-1588 Organisciak DT, Jiang YL, Wang HM, Bicknell I (1990) The protective effect of ascorbic acid in retinal light damage of

rats exposed to intermittent light. Invest Ophthalmol Vis Sci 31:1195-1202 Organisciak DT, Xie A, Wang HM, Jiang YL, Darrow RM, Donoso LA (1991) Adaptive-changes in visual cell trans-duction protein-levels-effect of light. Exp Eye Res 53:773-779

Organisciak DT, Bicknell IR, Darrow RM (1992) The effects of L-and D-ascorbic acid administration on retinal tissue levels and light damage in rats. Curr Eye Res 11:231-241 Organisciak DT, Darrow RM, Jiang YL, Blanks JC (1996) Retinal light damage in rats with altered levels of rod outer segment docosahexaenoate. Invest Ophthalmol Vis Sci 37:2243-2257

Organisciak DT, Darrow RM, Barsalou L, Darrow RA, Kutty RK, Kutty G, Wiggert B (1998) Light history and age-related changes in retinal light damage. Invest Ophthalmol Vis Sci 39:1107-1116 Packer L (1993) Antioxidant action of carotenoids in vitro and in vivo and protection against oxidation of human low-density lipoproteins. Ann NY Acad Sci 691:48-60 Pease PL, Adams AJ, Nuccio E (1987) Optical density of human

macular pigment. Vision Res 27:705-710 Penfold PL, Killingsworth MC, Sarks SH (1985) Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 223:69-76 Quan X, Lim SO, Jung G (2011) Reactive oxygen species downregulate catalase expression via methylation of a CpG island in the Oct-1 promoter. FEBS Lett 585:3436-3441 Ragsdale SW (2009) Nickel-based enzyme systems. J Biol

Chem 284:18571-18575 Ramkumar HL, Zhang J, Chan CC (2010) Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res 29:169-190 Ramkumar HL, Tuo J, de Shen F, Zhang J, Cao X, Chew EY, Chan CC (2013) Nutrient supplementation with n3 poly-unsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background. JNutr 143:1129-1135 Ranchon I, Gorrand JM, Cluzel J, Droy-Lefaix MT, Doly M (1999) Functional protection of photoreceptors from light-induced damage by dimethylthiourea and Ginkgo biloba extract. Invest Ophthalmol Vis Sci 40:1191-1199 Rapp LM, Williams TP (1979) Damage to the albino rat retina produced by low intensity light. Photochem Photobiol 29:731-733

Rapp LM, Williams TP (1980) The role of ocular pigmentation in protecting against retinal light damage. Vision Res 20:1127-1131

Recasens JF, Green K (1992) The effects of age and inflammation on antioxidant enzyme activity in the eye. AGE 15:114-117

Rex TS, Tsui I, Hahn P, Maguire AM, Duan D, Bennett J, Dunaief JL (2004) Adenovirus-mediated delivery of catalase to retinal pigment epithelial cells protects neighboring photoreceptors from photo-oxidative stress. Hum Gene Ther 15:960-967 Rozanowska M, Jarvis-Evans J, Korytowski W, Boulton ME, Burke JM, Sarna T (1995) Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 270:18825-18830

Ryoo HD, Domingos PM, Kang MJ, Steller H (2007) Unfolded protein response in a Drosophila model for retinal degeneration. EMBO J 26:242-252 Ryu E, Fridley BL, Tosakulwong N, Bailey KR, Edwards AO (2010) Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study. Mol Vis 17:2811-2821 Samiec PS, Drews-Botsch C, Flagg E, Kurtz JC, Sternberg P Jr, Reed RL, Jones DP (1998) Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 24: 699-704

SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL 3rd, Gensler GR, Lindblad AS, Milton RC, Seddon JM, Sperduto RD, Age-Related Eye Disease Study Research Group (2007) The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 125:671-679 Satarug S, Kikuchi M, Wisedpanichkij R, Li B, Takeda K, Na-Bangchang K, Moore MR, Hirayama K, Shibahara S (2008) Prevention of cadmium accumulation in retinal pigment epithelium with manganese and zinc. Exp Eye Res 87:587-593 Sato M, Bremner I (1993) Oxygen free radicals and metallo-

thionein. Free Radic Biol Med 14:325-337 Scott MD, Meshnick SR, Eaton JW (1987) Superoxide dismu-tase-rich bacteria: paradoxical increase in oxidant toxicity. J Biol Chem 262:3640-3645 Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT et al (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 272:1413-1420 Seddon JM, Gensler G, Klein ML, Milton RC (2006) C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age related macular degeneration. Nutrition 22:441-443 Shaban H, Gazzotti P, Richter C (2001) Cytochrome c oxidase inhibition by N-retinyl-N-retinylidene ethanolamine, a compound suspected to cause age-related macula degeneration. Arch Biochem Biophys 394:111-116 Shamsi FA, Boulton M (2001) Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest Ophthalmol Vis Sci 42:3041-3046 Shen XL, Jia JH, Zhao P, Fan R, Pan XY, Yang HM, Liu L (2012) Changes in blood oxidative and antioxidant parameters in a group of Chinese patients with age-related macular degeneration. J Nutr Health Aging 16:201-204 Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23:3394-3406 Sies H, Stahl W, Sundquist AR (1992) Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann NY Acad Sci 669:7-20 Singh S, Dao D, Srivastava S, Awasthi Y (1984) Purification and characterization of glutathione S-transferases in human retina. Curr Eye Res 3:1273-1280 Snellen EL, Verbeek AL, van Den Hoogen GW, Cruysberg JR, Hoyng CB (2002) Neovascular age-related macular

degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand 80:368-371 Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25:674-685 Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ (1998) Fruits and vegetables that are sources for lutein and zea-xanthin: the macular pigment in human eyes. Br J Oph-thalmol 82:907-910 Song D, Song Y, Hadziahmetovic M, Zhong Y, Dunaief JL (2012) Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. Free Radic Biol Med 53:64-71 Sparrow JR, Cai B (2001) Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest Ophthalmol Vis Sci 42:1356-1362 Sparrow JR, Nakanishi K, Parish CA (2000) The lipofuscin-fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41:1981-1989 Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K (2002) Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 43:1222-1227 Sparrow JR, Zhou J, Cai B (2003) DNA is a target of the pho-todynamic effects elicited in A2E-laden RPE by blue-light illumination. Invest Ophthalmol Vis Sci 44:2245-2251 Sreekumar PG, Spee C, Ryan SJ, Cole SPC, Kannan R, Hinton DR (2012) Mechanism of RPE cell death in a-crystallin deficient mice: a novel and critical role for MRP1-mediated GSH efflux. PLoS ONE 7:e33420 Strauss O (2005) The retinal pigment epithelium in visual

function. Physiol Rev 85:845-881 Synowiec E, Pogorzelska M, Blasiak J, Szaflik J, Szaflik JP (2012) Genetic polymorphism of the iron-regulatory pro-tein-1 and -2 genes in age-related macular degeneration. Mol Biol Rep 39:7077-7087 Synowiec E, Sliwinski T, Danisz K, Blasiak J, Sklodowska A, Ro-maniuk D, Watala C, Szaflik J, Szaflik JP (2013) Association between polymorphism of the NQO1, NOS3 and NFE2L2 genes and AMD. Front Biosci (Landmark Ed) 18:80-90 Tanito M, Kaidzu S, Anderson RE (2007) Delayed loss of cone and remaining rod photoreceptor cells due to impairment of choroidal circulation after acute light exposure in rats. Invest Ophthalmol Vis Sci 48:1864-1872 Tantin D, Schild-Poulter C, Wang V, Hache RJ, Sharp PA (2005) The octamer binding transcription factor Oct-1 is a stress sensor. Cancer Res 65:10750-10758 Tate DJ Jr, Miceli MV, Newsome DA (1995) Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthal-mol Vis Sci 36:1271-1279 Tate DJ Jr, Miceli MV, Newsome DA (1997) Zinc induces catalase expression in cultured fetal human retinal pigment epithelial cells. Curr Eye Res 16:1017-1023 Tuo J, Bojanowski CM, Zhou M, Shen D, Ross RJ, Rosenberg KI, Cameron DJ, Yin C, Kowalak JA, Zhuang Z et al (2007) Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci 48:3827-3836

Ueta T, Inoue T, Furukawa T, Tamaki Y, Nakagawa Y, Imai H, Yanagi Y (2012) Glutathione peroxidase 4 is required for maturation of photoreceptor cells. J Biol Chem 287:7675-7682 van Herpen-Broekmans WMR, Klopping-Ketelaars IAA, Bots ML, Kluft C, Princen H, Hendriks HFJ, Tijburg LBM, van Poppel G, Kardinaal AFM (2004) Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol 19:915-921 Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 28:13574-13581 Viiri J, Hyttinen JMT, Ryhanen T, Rilla K, Paimela T, Kuusisto E, Siitonen A, Urtti A, Salminen A, Kaarniranta K (2010) p62/sequestosome 1 as a regulator of proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells. Mol Vision 16:1399-1414 Wassell J, Davies S, Bardsley W, Boulton M (1999) The pho-toreactivity of the retinal age pigment lipofuscin. J Biol Chem 20:23828-23832 Wiegand RD, Giusto NM, Rapp LM, Anderson RE (1983) Evidence for rod outer segment lipid peroxidation following constant illumination of the rat retina. Invest Ophthalmol Vis Sci 24:1433-1435 Wills NK, Kalariya N, Sadagopa Ramanujam VM, Lewis JR, Haji Abdollahi S, Husain A, van Kuijk FJ (2009) Human retinal cadmium accumulation as a factor in the etiology of age-related macular degeneration. Exp Eye Res 89:79-87 Witting LA (1965) Lipid peroxidation in vivo. J Am Oil Chem

Soc 42:908-913 World Health Organization (2013) Available at http://www.

who.int/en/. Accessed 10 Aug 2013 Wysokinski D, Danisz K, Blasiak J, Dorecka M, Romaniuk D, Szaflik J, Szaflik JP (2013) An association of transferrin gene polymorphism and serum transferrin levels with age-related macular degeneration. Exp Eye Res 106:14-23 Yang LP, Wu LM, Guo XJ, Tso MO (2007) Activation of endoplasmic reticulum stress in degenerating photorecep-tors of the rd1 mouse. Invest Ophthalmol Vis Sci 48: 5191-5198

Yang LP, Wu LM, Guo XJ, Li Y, Tso MO (2008) Endoplasmic reticulum stress is activated in light-induced retinal degeneration. J Neurosci Res 86:910-919 Youssef PN, Sheibani N, Albert DM (2011) Retinal light toxicity. Eye (Lond) 25:1-14 Yu BP (1994) Cellular defenses against damage from reactive

oxygen species. Physiol Rev 74:139-162 Yu DY, Cringle SJ (2001) Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 20:175-208

Zadlo A, Rozanowska MB, Burke JM, Sarna TJ (2007) Photo-bleaching of retinal pigment epithelium melanosomes reduces their ability to inhibit iron-induced peroxidation of lipids. Pigment Cell Res 20:52-60 Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H (2002) p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160:255-263

Zhang J, Tuo J, Shen D, Li W, Chan C-C (2013) Early degeneration of photoreceptor synapse in Ccl2/Cx3cr1 deficient mice on Crb1rd8 background. Synapse 67(8):515-531 Zhong Y, Li J, Wang JJ, Chen C, Tran JT, Saadi A, Yu Q, Le YZ, Mandal MN, Anderson RE, Zhang SX (2012) X-box binding protein 1 is essential for the anti-oxidant defense

and cell survival in the retinal pigment epithelium. PLoS ONE 7:e38616

Zhuo P, Goldberg M, Herman L, Lee BS, Wang H, Brown RL, Foster CB, Peters U, Diamond AM (2009) Molecular consequences of genetic variations in the glutathione per-oxidase 1 selenoenzyme. Cancer Res 69:8183-8190